| CANCER RESEARCH TECHNOLOGY LTD Patent applications |
| Patent application number | Title | Published |
|---|
| 20110165180 | Polypeptides capable of binding to CD64 comprising one or more heterologous T cell epitopes and their uses - The invention relates to the use of a polypeptide that comprises i) a first portion comprising the part of human Fc that binds to CD64, and ii) a second portion comprising one or more heterologous T cell epitopes for stimulating a cytotoxic T cell response. The polypeptide may be an antibody that may be used to stimulate a cytotoxic T cell response against pathogens and tumour cells in patients in need of such treatment. | 07-07-2011 |
| 20100189776 | ANTI-ANDROGEN PEPTIDES AND USES THEREOF IN CANCER THERAPY - The present invention relates to isolated or purified or partially purified peptide derived molecules having the following general formula (S1): X-[(Pro) | 07-29-2010 |
| 20100179138 | Isozazole Compounds As Inhibitors Of Heat Shock Proteins - Isoxazoles of formula (A) or (B) are inhibitors of HSP90 activity, and useful for treatment of, for example cancers: | 07-15-2010 |
| 20100120767 | Pyrimidothiophene Compounds - Compounds of formula (1) are inhibitors of HSP90 activity in vitro or in vivo, and of use in the treatment of inter alia, cancer: wherein R | 05-13-2010 |
| 20090169472 | METHODS AND COMPOSITIONS FOR TREATING IMMUNE DISORDERS - The present invention provides oligonucleotides, compositions comprising them and methods that use the oligonucleotides and compositions for stimulating cells expressing the TLR7 and/or TLR8 receptor. The oligonucleotides comprise for stimulating TLR7 comprise uracil-rich regions. The oligonucleotides for stimulating TLR8 comprise guanine-rich regions. The present methods and compositions are useful, inter alia, for treating or preventing conditions such as infectious disease and cancer. | 07-02-2009 |
| 20090069336 | PYRIMIDOTHIOPHENE COMPOUNDS - Compounds of formula (I) are inhibitors of HSP90, and useful in the treatment of, for example, cancers: | 03-12-2009 |
| 20090054421 | Pyrimidothiophene Compounds Having HSP90 Inhibitory Activity - Compounds of formula (I) are HSP90 inhibitors, of utility in the treatment of, for example, cancers: wherein R | 02-26-2009 |
